Six aging clocks agree an AI-designed lung drug lowered patients' biological age
The finding is a secondary analysis of a lung fibrosis trial, and a Nobel laureate quoted in the announcement says it cannot yet tell slower ageing from a treated lung.
Company
Insilico Medicine is an organisation working in artificial intelligence, founded in 2014 and based in Boston, United States. This page collects every Aivio News story about Insilico Medicine, together with its models and recorded benchmark results.
Six aging clocks agree an AI-designed lung drug lowered patients' biological age
The finding is a secondary analysis of a lung fibrosis trial, and a Nobel laureate quoted in the announcement says it cannot yet tell slower ageing from a treated lung.
Privacy preferences
We use necessary cookies to run this site. With your consent we also use advertising cookies. You can change your choice at any time. Cookie Policy · Privacy Policy